Clinical trial
A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children Aged 5 to 11 Years in Brazil
NCT05403307 is registered in ClinicalTrials.gov with Hospital Moinhos de Vento as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children Aged 5 to 11 Years in Brazil
- Lead sponsor
- Hospital Moinhos de Vento
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 8, 2022
- Completion date
- July 17, 2023
- Enrollment
- 757 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.